US Study Reveals Alarming 310-Fold Rise in Obesity Drug Prescriptions for Young Children
A new study examining over 3.5 million American children aged 8-11 with obesity has found a dramatic increase in prescriptions for GLP-1 class drugs, used for weight loss. The research, published in the journal Pediatrics, observed a 310-fold surge in these prescriptions between January 2019 and June 2026, rising from 0.03% to 9.3% in 2026. Despite this sharp rise, the study emphasizes that the use of these drugs in this age group remains uncommon, with only about 0.6% of all children in the study receiving a prescription over the entire period.
The researchers noted that prescriptions were more common for older children within the age group, girls, and those with obesity-related health conditions, suggesting doctors are prioritizing children at higher cardiometabolic risk. The study also uncovered socioeconomic disparities, with children from lower social vulnerability areas receiving prescriptions at a higher rate than those from more disadvantaged areas.
It is important to note that some GLP-1 medications are approved for obesity treatment in individuals aged 12 and older, but not routinely for weight loss in children under 12. Therefore, prescribing these drugs to younger children constitutes an off-label use, requiring careful medical evaluation of potential benefits versus risks.
The study's authors caution that there is a lack of information regarding the long-term effects of these drugs on young children, including impacts on growth, development, muscle mass, digestive health, and mental well-being. The findings are based on observational data and do not prove the treatment's efficacy or safety for all children. The article also raises questions about whether similar trends are emerging in Israel and if adequate monitoring mechanisms are in place.
Childhood obesity is a chronic condition linked to increased risks of diabetes, high blood pressure, and sleep apnea. However, the article concludes that drug treatment for young children is not a quick fix and requires comprehensive management by a specialized medical team, alongside lifestyle and family habit changes.
